Covovax Approved for Kids Aged 7 to 11 Years
On June 24, the DCGI’s Subject Expert Committee had recommended emergency use authorization to Covovax vaccine for use in children aged 7-11.
As per the source, the DCGI has also approved India’s first indigenously developed mRNA vaccine against Covid-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use for those aged 18 years and above.
The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group, subject to certain conditions, on March 9.
Source: IANS
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.